Evidence map›Paper›PMID 27329753›Full record

ArticlemBio2016

Staphylococcus aureus Coordinates Leukocidin Expression and Pathogenesis by Sensing Metabolic Fluxes via RpiRc.

Divya Balasubramanian, Elizabeth A Ohneck, Jessica Chapman, Andy Weiss, Min Kyung Kim, Tamara Reyes-Robles, Judy Zhong, Lindsey N Shaw, Desmond S Lun, Beatrix Ueberheide and 2 more

Open access · goldAbstract read
In one paragraph

Article in mBio, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 68 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Quorum-sensingeLife · 2024
    Article
  10. Article
  11. Quorum-sensingbioRxiv : the preprint server for biology · 2024
    Article
  12. Infection and immunity · 2024
    Article
  13. Article
  14. Article
  15. Microbiology spectrum · 2023
    Article
  16. Article
  17. Antimicrobial agents and chemotherapy · 2022
    Observational
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Divya BalasubramanianDepartment of Microbiology, New York University School of Medicine, New York, New York, USA.
Elizabeth A OhneckDepartment of Microbiology, New York University School of Medicine, New York, New York, USA.
Jessica ChapmanProteomics Resource Center, Office of Collaborative Science, New York University School of Medicine, New York, New York, USA.
Andy WeissDepartment of Cell Biology, Microbiology and Molecular Biology, University of South Florida, Tampa, Florida, USA.
Min Kyung KimCenter for Computational and Integrative Biology and Department of Computer Science, Rutgers University, Camden, New Jersey, USA.
Tamara Reyes-RoblesDepartment of Microbiology, New York University School of Medicine, New York, New York, USA.
Judy ZhongDepartment of Population Health, Division of Biostatistics, New York University School of Medicine, New York, New York, USA.
Lindsey N ShawDepartment of Cell Biology, Microbiology and Molecular Biology, University of South Florida, Tampa, Florida, USA.
Desmond S LunCenter for Computational and Integrative Biology and Department of Computer Science, Rutgers University, Camden, New Jersey, USA.
Beatrix UeberheideProteomics Resource Center, Office of Collaborative Science, New York University School of Medicine, New York, New York, USA Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, New York, USA.
Bo ShopsinDepartment of Microbiology, New York University School of Medicine, New York, New York, USA Division of Infectious Diseases, Department of Medicine, New York University School of Medicine, New York, New York, USA.
Victor J TorresDepartment of Microbiology, New York University School of Medicine, New York, New York, USA victor.torres@nyumc.org.
New York University · USRutgers, The State University of New Jersey · USUniversity of South Florida · US

Funding

Mechanistic Studies Of The Staphylococcus aureus LukAB CytotoxinR01AI099394 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Victor J. Torres · 2013 to 2026
$6.1M
Contribution of LukED to Staphylococcus aureus pathobiologyR01AI105129 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI TORRES, VICTOR J. · 2014 to 2023
$4.9M
Role of precipitous virulence in invasiveness of community-acquired methicillin-rR01AI103268 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SHOPSIN, BO, TORRES, VICTOR J. · 2013 to 2017
$2.1M
Characterization of ??S in the stress & virulence responses of S. aureusR01AI080626 · NIAID · UNIVERSITY OF SOUTH FLORIDA · PI SHAW, LINDSEY NEIL · 2010 to 2013
$1.3M
Mechanistic studies of rot-mediated regulation of Staphylococcus aureus virulenceR21AI101533 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI TORRES, VICTOR J. · 2013 to 2014
$466k
Staphylococcus aureus mediated targeting and killing of immune cellsF31AI112290 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI REYES-ROBLES, TAMARA · 2014 to 2015
$62k
NIAID NIH HHS F31 AI112290NIAID NIH HHS HHSN272200700055CNIAID NIH HHS R01 AI080626NIAID NIH HHS R01 AI099394NIAID NIH HHS R01 AI103268NIAID NIH HHS R01 AI105129NIAID NIH HHS R21 AI101533
6 · The paper itself

Abstract

unlabelledStaphylococcus aureus is a formidable human pathogen that uses secreted cytolytic factors to injure immune cells and promote infection of its host. Of these proteins, the bicomponent family of pore-forming leukocidins play critical roles in S. aureus pathogenesis. The regulatory mechanisms governing the expression of these toxins are incompletely defined. In this work, we performed a screen to identify transcriptional regulators involved in leukocidin expression in S. aureus strain USA300. We discovered that a metabolic sensor-regulator, RpiRc, is a potent and selective repressor of two leukocidins, LukED and LukSF-PV. Whole-genome transcriptomics, S. aureus exoprotein proteomics, and metabolomic analyses revealed that RpiRc influences the expression and production of disparate virulence factors. Additionally, RpiRc altered metabolic fluxes in the trichloroacetic acid cycle, glycolysis, and amino acid metabolism. Using mutational analyses, we confirmed and extended the observation that RpiRc signals through the accessory gene regulatory (Agr) quorum-sensing system in USA300. Specifically, RpiRc represses the rnaIII promoter, resulting in increased repressor of toxins (Rot) levels, which in turn negatively affect leukocidin expression. Inactivation of rpiRc phenocopied rot deletion and increased S. aureus killing of primary human polymorphonuclear leukocytes and the pathogenesis of bloodstream infection in vivo. Collectively, our results suggest that S. aureus senses metabolic shifts by RpiRc to differentially regulate the expression of leukocidins and to promote invasive disease. IMPORTANCE: The bicomponent pore-forming leukocidins play pivotal roles in the ability of S. aureus to kill multiple host immune cells, thus enabling this pathogen to have diverse tissue- and species-tropic effects. While the mechanisms of leukocidin-host receptor interactions have been studied in detail, the regulatory aspects of leukocidin expression are less well characterized. Moreover, the expression of the leukocidins is highly modular in vitro, suggesting the presence of regulators other than the known Agr, Rot, and S. aureus exoprotein pathways. Here, we describe how RpiRc, a metabolite-sensing transcription factor, mediates the repression of two specific leukocidin genes, lukED and pvl, which in turn has complex effects on the pathogenesis of S. aureus Our findings highlight the intricacies of leukocidin regulation by S. aureus and demonstrate the involvement of factors beyond traditional virulence factor regulators.

Indexed as

Gene Expression Regulation, BacterialAmino AcidsAnimalsBacterial ProteinsCells, CulturedCell SurvivalCitric Acid CycleDisease Models, AnimalDNA Mutational AnalysisGene DeletionGene Expression ProfilingGlycolysisHumansLeukocidinsMetabolic Flux AnalysisMetabolomeAgr protein, Staphylococcus aureusAmino AcidsBacterial ProteinsLeukocidinsProteomeRepressor ProteinsTrans-ActivatorsVirulence Factors

Identifiers

PMID27329753
PMCPMC4916384
OpenAlexW2466306576

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.